Yoshihide Kimura
5PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|May 03, 2025
Neutrophil-to-lymphocyte ratio at the start of the second course of durvalumab plus tremelimumab therapy predicts therapeutic efficacy in patients with advanced hepatocellular carcinoma: A multicenter analysis.Takanori Suzuki, Kentaro Matsuura, Satoshi Sobue
|Dec 22, 2023
Serum CXCL10 levels at the start of the second course of atezolizumab plus bevacizumab therapy predict therapeutic efficacy in patients with advanced BCLC stage C hepatocellular carcinoma: A multicenter analysis.Takanori Suzuki, Kentaro Matsuura, Yuta Suzuki
|Feb 01, 2023
The neutrophil-to-lymphocyte ratio at the start of the second course during atezolizumab plus bevacizumab therapy predicts therapeutic efficacy in patients with advanced hepatocellular carcinoma: A multicenter analysis.Sho Matoya, Takanori Suzuki, Kentaro Matsuura
|Dec 08, 2022
Efficacy of minocycline hydrochloride aspiration sclerotherapy with additional monoethanolamine oleate aspiration sclerotherapy for symptomatic hepatic cysts.Yoshihide Kimura, Kei Fujiwara, Kentaro Matsuura
|Dec 03, 2022
Outcome of nucleos(t)ide analog cessation in patients with treatment for prevention of or against hepatitis B virus reactivation.Takanori Suzuki, Kentaro Matsuura, Kenji Urakabe
Pageof 1
